Risk of Pneumonia in Patients with COPD Initiating Fixed Dose Inhaled Corticosteroid (ICS) / Long-Acting Bronchodilator (LABD) Formulations Containing Extrafine Beclometasone Dipropionate versus Patients Initiating LABD Without ICS

IF 2.3 Q2 MEDICINE, GENERAL & INTERNAL

Pragmatic and Observational Research Pub Date : 2024-01-01 DOI:10.2147/por.s438031

D. Price, William Henley, J. Cançado, Leonardo Fabbri, H. Kerstjens, A. Papi, Nicolas Roche, Elif Şen, Dave Singh, Claus Vogelmeier, E. Nudo, V. Carter, Derek Skinner, Rebecca Vella, Joan Soriano, M. Kots, George Georges

引用次数: 0

查看原文本刊更多论文

慢性阻塞性肺病（COPD）患者开始使用含特级贝氯米松二丙酸酯的固定剂量吸入式皮质类固醇（ICS）/长效支气管舒张剂（LABD）制剂与开始使用不含 ICS 的 LABD 患者的肺炎风险比较

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Pragmatic and Observational Research MEDICINE, GENERAL & INTERNAL-

自引率

0.00%

发文量

期刊介绍： Pragmatic and Observational Research is an international, peer-reviewed, open-access journal that publishes data from studies designed to closely reflect medical interventions in real-world clinical practice, providing insights beyond classical randomized controlled trials (RCTs). While RCTs maximize internal validity for cause-and-effect relationships, they often represent only specific patient groups. This journal aims to complement such studies by providing data that better mirrors real-world patients and the usage of medicines, thus informing guidelines and enhancing the applicability of research findings across diverse patient populations encountered in everyday clinical practice.